Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment

NCT01083147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-09-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.

Conditions

  • Age-Related Macular Degeneration

Interventions

DEVICE

FORESEE HOME

Home Monitoring

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Daniel Roth, MD · Vitreos retina center - NJ

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-03-31
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083147 on ClinicalTrials.gov